Notice Pursuant to the National Cooperative Research and Production Act of 1993-UHD Alliance, Inc., 52094-52095 [2024-13659]

Download as PDF 52094 Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices Houston, TX; The Regents of the University of California, San Francisco, San Francisco, CA; The University of Kansas Medical Center Research Institute, Inc., Kansas City, KS; The University of Texas at Arlington, Arlington, TX; The University of Texas Health Science Center at San Antonio, San Antonio, TX; Tonix Pharmaceuticals, Chatham, NJ; TQIntelligence, Inc., Tucker, GA; Tremedics Medical Devices LLC, Fort Worth, TX; Trustees of the University of Pennsylvania dba Clinical Practices of the University of Pennsylvania, Philadelphia, PA; UC Berkeley Haas Institute for Business Innovation, Berkeley, CA; UCSF: Eureka Research Platform, San Francisco, CA; University of Alabama at Birmingham, Birmingham, AL; University of Chicago, Chicago, IL; University of Colorado Anschutz Medical Campus, Aurora, CO; University of Iowa, Iowa City, IA; University of Massachusetts Medical School, Worcester, MA; University of the Virgin Islands, St. Thomas, VI; University of Utah, Salt Lake City, UT; Vanderbilt University Medical Center, Nashville, TN; Women’s Health Access Matters, Greenwich, CT; Yunu, Inc., Cary, NC; and ZS Associates, Inc., Evanston, IL, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and the CX Hub intends to file additional written notifications disclosing all changes in membership. On January 11, 2024, the CX Hub filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on April 16, 2024 (89 FR 26929). [FR Doc. 2024–13623 Filed 6–20–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE ddrumheller on DSK120RN23PROD with NOTICES1 Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Senior Healthcare Innovation Consortium Notice is hereby given that, on April 4, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 17:46 Jun 20, 2024 Jkt 262001 Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–13614 Filed 6–20–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—DVD Copy Control Association Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. VerDate Sep<11>2014 et seq. (‘‘the Act’’), Senior Healthcare Innovation Consortium (SHIC) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Access Sensor Technologies LLC, Fort Collins, CO; Clarivate Analytics (US) LLC, Ann Arbor, MI; EchoCare, Ness Ziona, ISRAEL; GaitBetter, Rockville, MD; and North Dakota State University, Fargo, ND, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and SHIC intends to file additional written notifications disclosing all changes in membership. On November 02, 2022, SHIC filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on November 23, 2022 (87 FR 71677). The last notification was filed with the Department on January 9, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on February 6, 2024 (89 FR 8245). Notice is hereby given that, on April 24, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), the DVD Copy Control Association (‘‘DVD CCA’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Specifically, Nuvoton Technology Corporation, Kyoto, JAPAN, has been added as a party to this venture. Also, Fuji Film Media Crest Co., Ltd., Tokyo, JAPAN, has withdrawn as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and DVD CCA intends to file additional written notifications disclosing all changes in membership. On April 11, 2001, DVD CCA filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on August 3, 2001 (66 FR 40727). The last notification was filed with the Department on December 20, 2023. A notice was published in the Federal Register pursuant to section 6(b) of the Act on February 6, 2024 (89 FR 8244). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–13628 Filed 6–20–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—UHD Alliance, Inc. Notice is hereby given that, on May 6, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), UHD Alliance, Inc. (‘‘UHD Alliance’’) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, XGIMI Technology Co., Ltd., Chengdu, PEOPLE’S REPUBLIC OF CHINA, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and UHD Alliance intends to file additional written notifications disclosing all changes in membership. On June 17, 2015, UHD Alliance filed its original notification pursuant to section 6(a) of the Act. The Department E:\FR\FM\21JNN1.SGM 21JNN1 Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 17, 2015 (80 FR 42537). The last notification was filed with the Department on January 25, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on April 16, 2024 (89 FR 26926). DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Alliance for OpenUSD Series LLC ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE P Notice Pursuant to the National Cooperative Research and Production Act of 1993—Rapid Response Partnership Vehicle BILLING CODE 4410–11–P Notice is hereby given that, on April 25, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Alliance for OpenUSD Series LLC (‘‘AOUSD’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing additions or changes to its standards development activities. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, AOUSD has formed two additional Working Groups (‘‘WGs’’) in March 2024: a Materials WG and a Geometry WG. The Materials WG will standardize the description of materials in OpenUSD. Its initial focus and first deliverable will be the USD Material Interchange Specification, which will comprise a set of patterns and BSDF nodes comprising the MaterialX standard libraries. The Geometry WG will define and evolve the strategy for the description of 3D geometry in OpenUSD. Its first deliverable will be the USD Transformable 3D Geometry Specification that will describe the surfaces and volume representations, spatial transformations, rules of determining primary visibility, and other properties required for imaging those representations. On October 30, 2023, AOUSD filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Jkt 262001 [FR Doc. 2024–13636 Filed 6–20–24; 8:45 am] Antitrust Division [FR Doc. 2024–13659 Filed 6–20–24; 8:45 am] 17:46 Jun 20, 2024 Suzanne Morris, Deputy Director, Civil Enforcement Operations, Antitrust Division. DEPARTMENT OF JUSTICE Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. VerDate Sep<11>2014 Act on December 15, 2023 (88 FR 86939). Notice is hereby given that, on April 12, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Rapid Response Partnership Vehicle (‘‘RRPV’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, A-line, Inc., Signal Hill, CA; ANP Technologies, Inc., Newark, DE; ARNAV Biotech Corp., Atlanta, GA; Action Medical Technologies LLC, Conshohocken, PA; AmerStem, Inc., Camarillo, CA; American Type Culture Collection, Manassas, VA; Aposense, Ltd., Petach Tikva, ISRAEL; Appili Therapeutics USA, Inc., Frederick, MD; Aptitude Medical Systems, Goleta, CA; Arranta Bio MA LLC, Watertown, MA; Asha Therapeutics LLC, Tampa, FL; BDO Public Sector LLC, Mclean, VA; BRCR Medical Center, Inc., Plantation, FL; Battelle Memorial Institute, Columbus, OH; BioInfoExperts LLC, Thibodaux, LA; Boost Biopharma, Inc., Amherst, MA; Bracane Company, Plano, TX; Capra Biosciences, Inc., Manassas, VA; Capricor Therapeutics, Inc., San Diego, CA; CellCarta Biosciences, Inc., Montreal, CANADA; Cerba Research USA, Inc., Lake Success, NY; Clarametyx Biosciences, Inc., Columbus, OH; Clarus Biologics, Inc., Chapel Hill, NC; Cue Health, Inc., San Diego, CA; D’Angelo Technologies LLC, Beavercreek, OH; DEKA Research & Development Corp., Manchester, NH; Datavant, Phoenix, AZ; Deutsches Zentrum für Infektionsforschung e.V., Braunschweig, GERMANY; Diagnostic Consulting Network LLC dba DCN Diagnostics, Carlsbad, CA; Diasorin Molecular, Cypress, CA; EMD Millipore dba MilliporeSigma, Burlington, MA; PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 52095 Ethris GmbH, Planegg, GERMANY; FONDAZIONE BIOTECNOPOLO DI SIENA, SIENA, ITALY; Flagship Labs, Cambridge, MA; Fred Hutchinson Cancer Center, Seattle, WA; Genentech, South San Francisco, CA; GiwoTech, Inc., Wilmington, DE; Global Action Alliance, Inc., Ashburn, VA; HDT Bio Corp., Seattle, WA; Hope Biosciences, Sugar Land, TX; IQVIA Government Solutions, Inc., Falls Church, VA; Icahn School of Medicine at Mount Sinai, New York, NY; InBios International, Seattle, WA; Injection Safety Industries LLC, Bowling Green, KY; Inovio Pharmaceuticals, Plymouth Meeting, PA; Integrated Biotherapeutics LLC dba IBT Bioservices, Rockville, MD; LTS Lohmann Therapie-Systeme AG, Andernach, GERMANY; Labcorp, Burlington, NC; Labcorp-Monogram Biosciences, South San Francisco, CA; Lyndra Therapeutics, Inc., Watertown, MA; Major, Inc., Los Angeles, CA; MalarVx, Inc., Seattle, WA; Mirimus, Inc., Brooklyn, NY; Nature’s Toolbox, Inc., Rio Rancho, NM; New Horizon Biotech, Inc., Nazareth, PA; OncoC4, Inc., Rockville, MD; PIF Partners LLC, Englewood, NJ; PharmaJet, Inc., Golden, CO; Precision for Medicine, Inc., Frederick, MD; Revvity Health Sciences, Hopkinton, MA; Rocketvax, Ltd., Basel, SWITZERLAND; Selva Therapeutics, Inc., San Mateo, CA; Sentio BioSciences LLC, Maryland Heights, MO; Solaris Vaccines, Inc., Fort Collins, CO; Spring Discovery, Inc., San Carlos, CA; Technical Resources International, Inc., Bethesda, MD; The Emmes Company LLC, Rockville, MD; The Pandemic Institute (Legally hosted by the University of Liverpool), Liverpool, UNITED KINGDOM; Tonix Pharmaceutical Holdings, Chatham, NJ; Trawsfynydd Therapeutics, Inc., Rockville, MD; US Specialty Formulations LLC, Allentown, PA; Univercells S.A., Brussels, BELGIUM; VaxForm LLC, Bethlehem, PA; VisMederi Srl, Siena, ITALY; Vyriad, Inc., Rochester, MN; Walgreen Co., Deerfield, IL; Yourbio Health, Medford, MA; and iosBio, Ltd., Haywards Heath, UNITED KINGDOM, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and RRPV intends to file additional written notifications disclosing all changes in membership. On January 5, 2024, RRPV filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal E:\FR\FM\21JNN1.SGM 21JNN1

Agencies

[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Pages 52094-52095]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13659]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--UHD Alliance, Inc.

    Notice is hereby given that, on May 6, 2024, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), UHD Alliance, Inc. (``UHD 
Alliance'') filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, XGIMI Technology Co., Ltd., Chengdu, PEOPLE'S REPUBLIC OF 
CHINA, has been added as a party to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and UHD Alliance intends to file 
additional written notifications disclosing all changes in membership.
    On June 17, 2015, UHD Alliance filed its original notification 
pursuant to section 6(a) of the Act. The Department

[[Page 52095]]

of Justice published a notice in the Federal Register pursuant to 
section 6(b) of the Act on July 17, 2015 (80 FR 42537).
    The last notification was filed with the Department on January 25, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on April 16, 2024 (89 FR 26926).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13659 Filed 6-20-24; 8:45 am]
BILLING CODE 4410-11-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.